| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 |
| filingDate |
1977-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1978-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2364a879f29ed64a822540b8dbe13caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e5f902504bfc0046e40b4f62aa49f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffcd789ffe38d2bb5708ebdf56693b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21921c6ab5336cf7926d3285d38b3671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2f1c2a1fbac9fb320144d736282fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cd8a30dc672facc5f47449f70c904f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b5000c7a5daa7720d3eccf05a4d828 |
| publicationDate |
1978-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4131673-A |
| titleOfInvention |
N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| abstract |
N 2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277863-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5506241-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6087375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4201863-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5942620-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5214052-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4258192-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4634783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840733-A |
| priorityDate |
1974-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |